Home / Products /Genome Editing /WT Cell Line /Human acute myeloid leukemia cells (KG-1a)

Human acute myeloid leukemia cells (KG-1a)

Catalog Number: WT0013

Price:
$1000
Specifications Overview Application Downloads Related products

Specifications

Product Information
Product Name Human acute myeloid leukemia cells (KG-1a)
Specifications 1*10^6
Storage and transportation Dry ice preservation/T25 live cell transportation.
Cell morphology Lymphocyte like, suspended growth
Passage ratio 1:2-1:4
Mycoplasma testing negative
Cultivation System 90%RPMI-1640+10% FBS

Overview

Human acute myeloid leukemia cells (KG-1a) preserved using cutting-edge dry ice technology and expertly transported in T25 flasks offer a robust in vitro model to study lymphocyte-like suspended growth and therapeutic interventions in hematological malignancies ensuring optimal viability and functionality with a culture medium of RPMI-1640 supplemented with 10% FBS

Application

Human acute myeloid leukemia cells (KG-1a) are essential for advancing cancer research providing a reliable model for studying the biology and treatment of this aggressive disease particularly during live cell transportation and preservation using dry ice techniques These cells allow researchers to investigate the efficacy of novel therapeutic agents in lymphocyte-like suspended growth conditions facilitating experiments that mimic in vivo environments crucial for drug testing and development Additionally cultured KG-1a cells maintained in a 1:2 to 1:4 dilution in RPMI-1640 medium supplemented with 10% FBS enable scientists to assess cellular responses to various stimuli and treatments thereby enhancing our understanding of leukemia pathology and potential interventions

Downloads

Please note that all services are for research use only. Not intended for any clinical use.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.